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ABSTRACT
Introduction Degenerative cervical myelopathy (DCM) 
is a common, disabling and progressive neurological 
condition triggered by chronic compression of the cervical 
spinal cord by surrounding degenerative changes. Early 
diagnosis and specialist management are essential 
to reduce disability, yet time to diagnosis is typically 
prolonged. Lack of sufficient representation of DCM in 
undergraduate and postgraduate medical curricula may 
contribute to the poor recognition of DCM by non- specialist 
doctors in clinical practice.
In this study, our objective, therefore, is to assess DCM 
teaching provision in medical schools throughout the 
UK and to assess the impact of teaching on the DCM 
knowledge of UK medical students.
Methods and analysis A 19- item questionnaire capturing 
data on medical student demographics, myelopathy teaching 
and myelopathy knowledge was designed. Ethical approval 
was granted by the Psychology Research Ethics Committee, 
University of Cambridge. An online survey was hosted on  
Myelopathy. org, an international myelopathy charity. Students 
studying at a UK medical school are eligible for inclusion. 
The survey is advertised nationally through university social 
media pages, university email bulletins and the national 
student network of  Myelopathy. org. Advertisements are 
scheduled monthly over a 12- month recruitment period. 
Participation is incentivised by entering consenting 
participants of completed surveys to an Amazon voucher 
prize draw. Responses are anonymised using participant- 
chosen unique identifier codes. A participant information 
sheet followed by an explicit survey question captures 
participant informed consent. Regular updates on the 
progress of the study will be published on  Myelopathy. org.
Ethics and Dissemination Ethical approval for the 
study was granted by the Psychology Research Ethics 
Committee, University of Cambridge (PRE.2018.099). The 
findings of the study described in this protocol, and all 
other related work, will be submitted for publication in a 
peer- reviewed journal and will be presented at scientific 
conferences.
INTRODUCTION
Degenerative cervical myelopathy (DCM) 
is a common neurological condition of 
symptomatic cervical spinal cord compres-
sion due to degenerative changes of the spine 
(figure 1).1 DCM is the most common cause 
of spinal cord impairment in adults world-
wide, with an estimated prevalence of up to 
5% in the over 40s.1–3
Substantial improvements in the care of 
patients with DCM could be realised today 
without any additional scientific under-
standing of the condition.1 Patients with 
DCM almost universally experience diag-
nostic delays. For example, one study demon-
strated that on average it took 2 years and five 
clinic appointments before the diagnosis was 
made.4 Improvement in diagnosis is there-
fore a key target that would provide imme-
diate reductions in disability.5
Initially, patients with DCM are commonly 
seen by primary care, emergency and medical 
physicians.6 7 These non- specialist triage 
points appear key to earlier diagnosis, yet 
DCM features poorly in medical curricula.8 
This risks non- specialist doctors being poorly 
equipped to detect DCM.
The current focus and makeup of DCM 
medical education are unclear. Our recent 
Strengths and limitations of this study
 ► This is a large national questionnaire- based study 
targeted at all medical students in the UK.
 ► This is the first study to assess degenerative cervical 
myelopathy (DCM) medical education in the UK.
 ► This is a student- led study with oversight from se-
nior researchers and involvement of patients with 
DCM.
 ► The study data will provide insight into an area that 
has potential to translate into substantial improve-
ments in patient outcomes.
 ► Risk of selection bias may overestimate the current 
knowledge of DCM among UK medical students.
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evaluation of undergraduate and postgraduate medical 
curricula identified deficiencies in DCM representation, 
however, collectively this did not correlate with student 
performance in multiple- choice question banks.8
The aim of this study is to describe the teaching of DCM in 
UK medical schools and to assess the influence on medical 
student knowledge of DCM. Ultimately, the aim is to identify 
both training and knowledge gaps to inform guidance on 
DCM education in order to address the burden and impact 
of delayed diagnosis. We hypothesise that knowledge and 
awareness among medical professionals are related to their 




 Myelopathy. org is an international cervical myelopathy 
charity, which aims to improve health and wellbeing in 
DCM.9 This study forms part of a wider project to eval-
uate DCM education and awareness among medical 
professionals in the UK and develop focused and effective 
interventions to improve this. This includes our recent 
gap analysis of key medical resources and knowledge at 
each stage of the primary care training pathway8 and an 
educational article on DCM for non- specialist medical 
professionals, commissioned by the British Medical Journal 
(figure 2).1 The charity is focused on understanding 
how medical education can be improved as one possible 
strategy to address the current problems of delayed, 
missed and underdiagnosis.1
Student Society of  Myelopathy. org
The foundations of professional knowledge begin with 
students’ formative experiences at medical school. There-
fore, the Student Society of  Myelopathy. org was established 
in 2018 with the aim of improving DCM engagement and 
awareness among medical students. The society remains 
in its infancy but has hosted a series of educational talks 
at the University of Cambridge; established national 
medical student essay and research prizes; designed and 
Figure 1 Typical MRI scan from patient with degenerative 
cervical myelopathy showing spinal cord compression and 
multilevel degenerative changes.
Figure 2 Degenerative cervical myelopathy educational article commissioned by the British Medical Journal. Reproduced with 
permission from British Medical Journal.
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initiated this current study and secured sponsorship from 
corporate partners to support these projects.
Study design
An electronic survey was agreed to be the most efficient 
way to simultaneously assess teaching, perceptions of 
teaching and current knowledge and to efficiently reach 
students from all UK medical schools. Part 1 of the survey 
was designed to capture data on basic demographic 
characteristics and teaching on DCM in UK medical 
schools. Part 2 was designed to capture data on knowl-
edge and awareness of fundamental DCM facts including 
prevalence, symptoms, diagnostic imaging modalities 
and surgical effectiveness in addition to appreciation of 
important current challenges such as prolonged time 
to diagnosis and poor patient quality of life. Part 2 was 
designed to capture participant’s perception of their 
DCM knowledge. These questions were considered to be 
a reasonable balance of capturing sufficient data while 
maintaining an acceptably short survey completion time 
of approximately 5 min.
The study management team comprised representa-
tion from second year to final year students from multiple 
UK medical schools. The team comprised an academic 
neurosurgical registrar (BD) and an academic neuro-
surgical consultant (MK), both with special clinical and 
academic interests in DCM, and an academic consul-
tant neurologist (S Stacpoole) who is a neuroscience 
teaching fellow and neuroscience course organiser at the 
University of Cambridge. Importantly, this is a student- 
motivated, student- led project with supervision, oversight 
and mentorship at all stages of the study from a team of 
senior researchers.
The survey was iteratively refined among the study 
management group until section 1 was felt to capture 
sufficient information on current DCM teaching provi-
sion in UK medical schools. Similarly, section 2 was 
refined until it was felt to evaluate fundamental DCM 
facts at a level sufficient for a non- specialist but qualified 
doctor to appropriately suspect, investigate, diagnose and 
redirect care in DCM. In total, a 19- item questionnaire 
was developed (figure 3).
Survey development closely aligns with the Association 
for Medical Education in Europe (AMEE) seven- step 
guide to medical education survey development: (1) liter-
ature review, (2) focus group establishment, (3) synthesis 
of literature review/focus group, (4) item development, 
(5) expert validation, (6) feedback and expert validation 
and (7) piloting,10 with the exception that a quantita-
tive gap analysis was performed in the place of a litera-
ture review due to the lack of research on DCM medical 
education at the time of study design.8 Nonetheless, plan-
ning for a systematic review of similar medical education 
surveys in other diseases is underway.
Survey piloting
The survey was piloted in January 2019 by a group of 20 
medical students at the University of Cambridge. These 
students were not directly involved in the design of the 
study. Data were inspected to identify any inconsistencies, 
ambiguities and problematic survey items. No issues were 
identified. Students in the pilot group were contacted to 
ask whether they had encountered any difficulties, areas 
of uncertainty or suggestions for improving the survey. 
Students reported the survey to be acceptable on both 
desktop and mobile devices. Informal cognitive interviews 
of five students revealed that survey items were interpreted 
by students as intended by the study team, without ambi-
guity. No further alterations were therefore made. No 
formal statistical data analysis was conducted at the pilot 
stage.
Survey administration
To maximise reach across the UK, the survey was hosted 
on Qualtrics survey software (Provo, Utah, USA), a profes-
sional online survey platform. Qualtrics survey software 
includes both desktop and mobile- compatible versions, 
maximising convenience for participants.
The survey comprises two pages. The first page acts as 
a frontpage consisting of a participant information sheet 
and a question capturing informed consent. The second 
page is the main survey page. It comprises 19 questions 
over a single page to minimise the number of clicks 
required for participants to complete the survey.
Survey dissemination
A network of  Myelopathy. org student representatives was 
recruited, with representation of students from 25 different 
medical schools across the UK. Some but not all were 
also representatives for the Society of British Neurolog-
ical Surgeons and Neurology and Neurosurgery Student 
Interest Group (NANSIG). A standard advertisement 
devised by the protocol development team and approved 
by the research ethics committee is used for all advertising 
(figure 4). Representatives from all medical schools are sent 
monthly reminder emails to disseminate adverts at their 
institution over a 12- month period from February 2019 
to January 2020. There was no difference in the timing 
of reminder emails between different medical schools. 
Although prompted to advertise monthly, the final decision 
on frequency of advertising at each institution is left to the 
discretion of representatives, guided by local rules.
On completion of the survey participants are invited to 
leave an email address in a separate Google Forms survey 
to be entered into a prize draw to win one of five £10 
Amazon vouchers. The prize draw was agreed by the study 
management group and approved by the research ethics 
committee. The rationale was that prizes of this value may 
encourage participation without providing an inappro-
priate incentive to participate.
The survey is advertised in social media groups and on 
social media pages for relevant student groups and soci-
eties at universities across the UK. For example, Facebook 
groups of surgical, neurosurgical, neurological and other 
medical student societies were approached. In addition, 
university mailing lists and email bulletins are being 
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used, where appropriate, in accordance with local rules. 
Adverts are also placed in the monthly NANSIG news-
letter, emailed out to medical student subscribers across 
the UK. The survey link is also hosted on the Student 
Society of  Myelopathy. org webpage and Facebook page.
Eligibility and representation
All UK medical students are eligible to complete the 
survey. We aim to secure representation of all UK medical 
schools.
Consent and confidentiality
A patient information sheet (PIS) including a question 
capturing informed consent forms the survey frontpage 
(figure 5). The PIS emphasises the rational, purpose, 
study aims and the voluntariness of participation. By 
necessity, the background information on DCM in the PIS 
is minimal to avoid compromising the DCM knowledge- 
based questions in the survey. A page block is used to 
separate the front and main survey pages.
Participants assign themselves a unique identifier 
based on a defined combination of characters from 
their mother’s maiden name, the street they grew 
up on and their mobile phone number; this ensures 
anonymity and confidentiality while allowing the possi-
bility of linking together future surveys from the same 
participant.
Figure 3 Final survey design. Reproduced with permission from Myelopathy.org.
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Data security
All data are stored exclusively on the secure, online Qual-
trics platform until closure of the survey. Thereafter, 
survey data will be extracted directly from the Qualtrics 
platform into a password- encrypted Excel spreadsheet 
(Microsoft, California, USA) on a password- protected 
computer. Only the immediate research team will be 
granted access to this on a need- to- access basis. After 
completion of data analysis, all data that are no longer 
required will be deleted. No participant- identifiable data 
will be collected or stored at any point.
Figure 5 Survey frontpage including patient information sheet and capturing of informed consent. Reproduced with 
permission from Myelopathy.org.
Figure 4 A standard advertisement devised by the protocol development team and approved by the research ethics 
committee is being used for all survey advertising. Reproduced with permission from Myelopathy.org.
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Statistical analysis
Data will be analysed in Microsoft Excel and using statis-
tical software.
Relationships between duration of DCM teaching, dura-
tion of private study on DCM and student perception of 
their DCM knowledge and objective performance in the 
DCM knowledge- based questions will be assessed. Differ-
ences in performance on the knowledge- based questions 
will be compared between groups based on medical 
school, year of medical school, duration of teaching, 
format of teaching, duration of private study, prior self- 
reported awareness of DCM, self- rating of DCM knowl-
edge and between groups of medical students wishing to 
pursue neurological/neurosurgical career specialties and 
those who do not.
Due to all items in the survey being mandatory, we 
anticipate that missing data will be minimal, however 
will conduct a missing data analysis as necessary. It is not 
expected the data will be suitable for imputation, thus 
we will compare demographics to establish any selec-
tion bias caused by the exclusion of missing values. We 
will perform analysis on all collected values. The survey 
findings will be presented using descriptive statistics. 
Inferential statistical tests may be used to consider the 
relationship between knowledge and educational provi-
sion. Distribution testing will be performed. Appropriate 
statistical methods will be selected based on the class and 
distribution of the data; it is anticipated data will be non- 
parametric, and as measures are recorded on an ordinal 
or categorial basis, will therefore be compared using tests 
such as χ2 or Kruksall- Wallis tests.
Patient and public involvement
Patients were involved in the conception, design, devel-
opment and conduct of this study. A DCM Patient and 
Public Engagement Day hosted at the University of 
Cambridge was captured by Cambridge TV in a docu-
mentary.11 During this day, a focus group of patients 
with DCM emphasised their experiences of diagnostic 
delays. This has been frequently echoed by patients 
in  Myelopathy. org social media groups and in a DCM 
word- cloud creating initiative to understand patient’s 
perceptions of the condition for a related project. 
Patients with DCM therefore inspired the conception of 
this study and approved the final survey design. Patients 
also assisted in the essential administrative tasks of the 
project, such as logo design. The online survey for the 
study was hosted on  Myelopathy. org, which is a patient- 
maintained website for people with DCM. Patients 
were, therefore, active in aiding the dissemination of 
the survey to UK medical students. Patients who were 
involved in preparation of the manuscript are among 
the authors. Patients with DCM are involved in plans 
to disseminate this research to the patient community, 
including blog articles on  Myelopathy. org, posts in 
online patient support groups and presence at spinal 
conferences in the UK.
DISCUSSION
Study rationale
This is the first study to describe the DCM education at 
medical schools nationally. Medical students are recruited 
to an online survey, including an assessment of their DCM 
knowledge and their personal DCM learning experience. 
By comparison of learning experience and knowledge, 
and also comparison between medical schools, it is antic-
ipated both the presence or absence of a knowledge 
gap can be evaluated, and the more successful teaching 
formats are identified. This will be used to inform  Myelop-
athy. org education recommendations.
Why assess DCM education?
DCM is a devastating condition with one of the poorest 
quality of life scores of any chronic disease.12 Symptoms 
include loss of manual dexterity, gait impairment, limb 
paraesthesia, limb weakness, limb stiffness, bladder and 
bowel disturbance, neck pain and neck stiffness.1 13 14 
The full spectrum of symptoms and the natural history 
of DCM are poorly appreciated,15 16 yet it remains clear 
that the condition poses a substantial burden on the phys-
ical and mental health of people with DCM17 and their 
supporters.18 There is a broad differential for DCM symp-
toms19 and poor consensus on what the most common 
DCM symptoms are. In addition, an increasing number of 
less well- described symptoms such as dysaesthetic sensory 
symptoms,6 chest tightness20 and headache21 are being 
reported.22 Neurological examination findings include 
upper motor neuron signs in the upper and lower limbs: 
spasticity and hyperreflexia in addition to weakness.1 14
The latest international guidelines23 recommend 
surgical decompression as the only evidence- based 
management24 25 for patients with moderate to severe, or 
progressive DCM. Surgery is also a management option 
in patients with mild DCM.23 Importantly, surgery can 
halt progression of the condition but is ineffective at 
reversing existing damage.25 Therefore, the traditional 
medical dogma that prevention is better than cure holds 
as strongly as ever in DCM: time is spine.1
Scientific advances are sorely needed to improve ther-
apeutic options and ultimately to cure disabled patients 
with DCM.26 27 However, while research into the neuro-
biology of DCM and neural regeneration,28 such as the 
RECEDE- Myelopathy and CSM- PROTECT trials offer 
hope for the future,9 29 30 even the most optimistic scien-
tist would concede that tangible benefits for patients 
arising from these technologies remain on the horizon: 
one systematic review reported average duration of knowl-
edge translation of 17 years from research to practice.31
Therefore, pragmatic approaches are required to 
improve outcomes for today’s patients with DCM. 
One such approach entails addressing the substan-
tial problem of diagnostic delays,1 which is expected to 
improve outcomes in this progressive condition.5 One 
method of instituting this may be through better educa-
tion. Indeed, a phenomenon of ‘neurophobia’ is well 
described among medical students and non- specialist 
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doctors.32–34 Additionally, evidence from our recent gap 
analysis suggests poor representation of DCM in medical 
curricula. These factors may point to a knowledge gap in 
DCM medical education.
Benefits of a medical student survey
Assessing teaching and knowledge among medical 
students is a pragmatic and initial step to evaluate a knowl-
edge gap. Medical school is the foundation of all medical 
professionals’ education and is especially important for 
instilling basic knowledge of important areas of medi-
cine that may fall outside a doctor’s future field of 
specialisation. It is likely that this is particularly pertinent 
for knowledge that this not later core (ie, built on or 
refined) during specialisation. For this purpose, a survey 
of medical students is best placed to simultaneously assess 
knowledge, while reporting on the current provision of 
DCM teaching and perceptions of it. Moreover, the survey 
itself may help to prime an audience to support a subse-
quent intervention, or at the very least raise awareness.
Urgent improvements in outcomes for patients with 
DCM are needed. Earlier diagnosis would improve 
outcomes based on current treatments. This study aims 
to evaluate DCM education and knowledge, and explore 
their relationship, among medical students. It is hoped 
this will inform educational interventions that may offer 
the greatest chance of shaping the non- specialist doctor’s 
diagnosis of DCM tomorrow.
LIMITATIONS
Online surveys are an effective method of reaching 
students from diverse medical schools.35 In addition, 
digital collection of data offers a secure and seamless 
stream, facilitating data analysis. However, their limitation 
is in understanding how representative the findings are.
In order to mitigate this, a number of different dissemi-
nation approaches are being employed. This includes the 
appointment of local representatives at each UK medical 
school, the use social media posts, society mailing lists, 
society newsletters, medical school email bulletins, 
medical school newsletters and also the use of prizes as an 
incentive.36 Additionally, the capture of participant demo-
graphics will help to measure the sample characteristics.
The engagement with open surveys often involves 
some predefined interest. It is possible therefore a selec-
tion bias towards students interested in neuroscience is 
more likely and results would be considered as a best- case 
scenario. While there is a risk of overlooking or under-
estimating the magnitude of a knowledge gap given the 
outlined benefits of this methodology, this is an accepted 
risk. Whatever the relationship between DCM teaching 
and knowledge turns out to be, it will be instructive with 
regards to the overall objective of identifying ways of 
improving DCM diagnosis.
We acknowledge that the wording of the survey item 
‘Do you think time to diagnosis is important for long- 
term prognosis?’ could be perceived as leading and would 
have been better phrased in a more neutral format such 
as ‘How important is time to diagnosis for long- term 
prognosis?’. We will monitor the performance of this item 
closely in our analysis.
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